Tumor biomarkers, the substances which are produced by tumors or the body's responses to
tumors during tumorigenesis and progression, have been demonstrated to possess critical …

Early diagnosis and treatment are crucial for breast cancer patients. Interstitial fluid (ISF)
shows promise for early disease screening, but its extraction for biomarker detection is …

Background Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related
morbidity and mortality worldwide. Immune checkpoint inhibitors (ICIs) including anti-PD-1 …

BACKGROUND Carcinoembryonic antigen (CEA) is an important serum tumour marker with
a substantial role in diagnosis and monitoring of various solid tumours. About 36%-70% of …

Introduction The largest transmembrane mucin, mucin 16 (MUC16), contains abundant
glycosylation sites on the molecular surface, allowing it to participate in various molecular …

Sarcopenia is correlated with poor clinical outcomes in breast cancer (BC) patients.
However, there is no precise quantitative study on the correlation between body composition …

Background Correlative interactions between electrical charges and cancer cells involve
important unknown factors in cancer diagnosis and treatment. We previously reported the …

Purpose Breast cancer patients typically have decent prognoses, with a 5-year survival rate
of more than 90%, but when the disease metastases to lymph node or distant, the prognosis …

The development of a specifically sensitive approach for CA15-3 detection is of great
significance for the early diagnosis and treatment monitoring of breast cancer. In the present …

Simple Summary Detecting cancer early significantly increases the chances of successful
(surgical) treatment. Pancreatic cancer is one of the deadliest cancer forms, since it is …